Erythrocyte membrane anionic charge in type 2 diabetic patients with retinopathy

BMC Ophthalmology

Volumn 4, Issue , 2004, Pages

  Budak, Yasemin ^a   Demirci, Hakan ^a   Akdogan, Muberra ^a   Yavuz, Dilek ^b  

^a SSK Sevket Yilmaz Hospital   (Turkey)

^b MARMARA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANION CHANNEL; GLYCOSAMINOGLYCAN; ALCIAN BLUE; ANION; COLORING AGENT; GLUCOSE BLOOD LEVEL; N ACETYLNEURAMINIC ACID;

ADULT; ARTICLE; BINDING SITE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ERYTHROCYTE MEMBRANE; FEMALE; HUMAN; MALE; MEMBRANE TRANSPORT; NON INSULIN DEPENDENT DIABETES MELLITUS; RETINOPATHY; URINARY EXCRETION; ALBUMINURIA; ANALYSIS; BLOOD; COMPARATIVE STUDY; DIABETIC RETINOPATHY; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; URINE;

ALBUMINURIA; ALCIAN BLUE; ANIONS; BLOOD GLUCOSE; COLORING AGENTS; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; ERYTHROCYTE MEMBRANE; FEMALE; GLYCOSAMINOGLYCANS; HUMANS; MALE; MIDDLE AGED; N-ACETYLNEURAMINIC ACID;

EID: 8844274841     PISSN: 14712415     EISSN: 14712415     Source Type: Journal    
DOI: 10.1186/1471-2415-4-14     Document Type: Article

References (33)

1. Merimee TJ: Diabetic retinopathy: a synthesis ofperspectives. N Engl J Med 1990, 322:978-983.
2. D'Amico DJ: Diseases of the retina. N Engl J Med 1994, 331:95-106.
3. Fong DS, Aiello L, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL, American Diabetes Association, Klein R: Diabetic retinopathy. Diabetes Care 32003, 26(Suppl 1):S99-S102.
4. Chaturvedi N, Sjoelie AK, Porta M, Aldington SJ, Fuller JH, Songini M, Kohner EM, EURODIAB Prospective Complications Study: Markers of insulin resistance are strong risk factors for retinopathy incidence in type 1 diabetes. Diabetes Care 2001, 24:284-289.
5. Kofoed-Enevoldsen A, Jensen T, Borch-Johnson K, Deckert T: Incidence of retinopathy in type 1 (insulin dependent) diabetes: association with clinical nephropathy. J Diabet Comp 1987, 1:96-99.
6. Jensen T: Albuminuria: a marker of renal and generalized vascular disease in insulin dependent diabetes mellitus. Dan Med Bull 1991, 38:134-144.
7. Deckert T, Feldt-Rasmussen B, Burch-Johnsen K, Jensen T, Kofoed-Enevoldsen A: Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 1989, 32:219-226.
8. Karwar YS, Linker A, Farquhar MG: Increased permeability of the glomerular basement membrane to ferritin after removal of glycosaminoglycan (heparan sulfate) by enzyme digestion. J Cell Biol 1980, 86:688-693.
9. Van den Born J, Van Kraats AA, Bakker MAH, Assmann KJM, Van den Heuvel LPWJ, Berden JHM: Selective proteinuria in diabetic nephropathy in the rat is associated with a relative decrease in glomerular basement membrane heparan sulfate. Diabetologia 1995, 38:161-172.
10. Gambaro G, Cicerello E, Mastrosimone S, Lavagninit BB: High urinary excretion of glycosaminoglycan: a possible marker of glomerular involvement in diabetes. Metabolism 1989, 38:419-420.
11. Gambaro G, Baggio B, Cicerello E, Mastrosimone S, Marzaro G, Borsatti A, Crepaldi G: Abnormal erythrocyte charge in diabetes mellitus. Link with microalbuminuria. Diabetes 1988, 37:745-748.
12. Beutler E, West C, Blume KG: The removal of leucocytes and platelets from whole blood. J Lab Clin Med 1976, 88:328-333.
13. Jong JGN, Wavera RA, Laarakkers C, Poorthhula BJHM: Dimethylene blue-based spectrophotometry of glycosaminoglycans in untreated urine: a rapid screening procedure for mucopolysaccharidosis. Clin Chem 1989, 35:1472-1477.
14. Crook M, Haq M, Tutt P: Evaluation of three assays for the determination of serum sialic acid. Clin Biochem 1993, 26:449-454.
15. Bernard A, Amor AO, Goemare-Vanneste J, Antoine JL, Lauweys I, Vandeleene B, Lambert A: Urinary proteins and red blood cell membrane negative charges in diabetes mellitus. Clin Chim Acta 1990, 190:249-262.
16. Estivi P, Cavallo-Perin P, Pagano G: Electrical anionic charges on red blood cells are reduced in insulin dependent diabetic patients. J Diabet Complications 1989, 3:45-48.
17. Yavuz D, Ersöz Ö, Küçükkaya B, Budak Y, Ahiskali R, Ekicioǧlu G, Emerk K, Akal n S: The effect of losartan and captopril on glomerular basement membrane anionic charge in a diabetic rat model. J Hyper 1999, 17:1217-1223.
18. Spicer SS, Schulte BA: Diversity of cell glycocongugates shown histochemically: a perspective. J Histochem Cytochem 1992, 40:1-38.
19. Gambaro G, Baggio B, Cicerello E, Mastrosimone S, Marzaro G, Borsatti A, Crepaldi G: Abnormal erythrocyte charge in diabetes mellitus. Link with microalbuminuria. Diabetes 1988, 37:745-748.
20. Chakrabarti S, Ma N, Sima AAF: Anionic sites in diabetic basement membranes and their possible role in diffusion barrier abnormalities in the BB-rat. Diabetologia 1991, 34:301-306.
21. Caldwell RB, Slapnick SM, McLaughin BJ: Decreased anionic sites in Bruch's membrane of spontaneous and drug-induced diabetes. Invest Ophtalmol Vis Sci 1986, 27:1691-1697.
22. Swell RF, Brendey PEC: Red cell surface charge in glomerular disease. Lancet 1986, 2:635-636.
23. Swell RF, Short CD: Minimal change nephropathy: how does the immune system affect the glomerulus. Nephrol Dialysis Transplant 1993, 8:108-112.
24. Carlson EC, Audette JL, Veitenheimer NJ, Risan JA, Laturnus DI: Ultrastructural morphometry of capillary basement membrane thickness in normal and transgenic diabetic mice. Anat Rec 2003, 271:332-341.
25. Das A, Frank RN, Zhang NL , Turezyn TJ: Ultrastructural localization of extracellular matrix components in human retinal vessels and Bruch's membrane. Arch Ophthalmol 1990, 108:421-429.
26. Kahaly G, Hansen C, Otto E, Forster G, Beyer J, Homme IG: Diabetic microangiopathy and urinary glycosaminoglycans. Exp Clin Endocrinol Diabetes 1997, 105:145-151.
27. Williamson JR, Chang K, Tilton RG, Prater C, Jeffrey JR, Weigel C, Sherman WR, Eades DM, Kilo C: Increased vascular permeability in spontaneously diabetic BB/W rats with mild versus severe streptozocin-induced diabetes. Prevention by aldose reductase inhibitors and castration. Diabetes 1987, 36:813-821.
28. Gin T, Joon TL, Panagiotopoulos S, Cooper M, Taylor H, Jerums G: Organ specificity of antihypertansive therapy on ocular albumin vascular clearence and albuminuria in hypertensive diabetic rat. Invest Ophthalmol Vis Sci 1996, 37:281-288.
29. Van der Pill , van der Woude FJ, Swat W, Van Es LA, Lemkes HH: Effect of danaparoid sodium on hard exudates in diabetic retinopathy. Lancet 1997, 350:1743-1745.
30. Kjellen L, Bielefeld D, Hook M: Reduced sulfatation of liver heparan sulfate in experimentally diabetic rats. Diabetes 1983, 32:337-342.
31. Kofoed-Enewoldsen A: Inhibition of glomerular glucosaminyl N- deacetylase in diabetic rats. Kidney Int 1992, 41:763-767.
32. Crook MA, Pickup JJC, Lumb PJ, Georgino F, Webb DJ, Fuller JH: Relationship between plasma sialic acid concentration and microvascular complications in type 1 diabetes. Diabetes Care 2001, 24:316-322.
33. Chen JW, Gall MA, Yokoyama H, Jensen JS, Deckert M, Parving HH: Raised serum sialic acid concentration in NIDDM patients with and without diabetic nephropathy. Diabetes Care 1996, 19:130-134.